BRIEF published on 01/20/2026 at 15:58, 16 days 13 hours ago Kopernik Global Investors crosses thresholds at EUROAPI Voting Rights Actions Crossing Thresholds EUROAPI Kopernik Global Investors
BRIEF published on 12/10/2025 at 17:50, 1 month 26 days ago Tristan Imbert Appointed as Independent Director at EUROAPI Pharmaceutical Industry Independent Director Audit Committee EUROAPI Tristan Imbert
PRESS RELEASE published on 12/10/2025 at 17:45, 1 month 26 days ago Tristan Imbert co-opted as Independent Director Tristan Imbert appointed Independent Director at EUROAPI, bringing expertise in pharmaceutical finance and strategy. Financial agenda includes FY 2025 results on 3 March 2026 and 2026 AGM on 27 May 2026 Financial Agenda Strategy EUROAPI Tristan Imbert Pharmaceutical Finance
BRIEF published on 09/18/2025 at 07:05, 4 months 17 days ago Science Based Targets initiative Validates EUROAPI's Climate Goals Sustainability GHG Emissions EUROAPI Climate Goals SBTi Validation
PRESS RELEASE published on 09/18/2025 at 07:00, 4 months 17 days ago Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets EUROAPI's near-term climate targets validated by the Science Based Targets initiative (SBTi) show significant reductions in greenhouse gas emissions, confirming alignment with the Paris Agreement Greenhouse Gas Emissions Science Based Targets Initiative Climate Targets Paris Agreement EUROAPI
BRIEF published on 06/30/2025 at 18:03, 7 months 5 days ago EUROAPI Divests Haverhill Site to Particle Dynamics Pharmaceutical EUROAPI FOCUS-27 Haverhill Sale Particle Dynamics
PRESS RELEASE published on 06/30/2025 at 17:58, 7 months 5 days ago EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan. Deal strengthens capabilities, market reach Acquisition EUROAPI FOCUS-27 Particle Dynamics Haverhill
BRIEF published on 06/19/2025 at 16:29, 7 months 16 days ago Goldman Sachs Crosses Thresholds in EUROAPI Voting Rights Actions Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 06/06/2025 at 16:03, 7 months 29 days ago EUROAPI General Assembly: Approval of Resolutions and Perspectives General Assembly EUROAPI Resolutions Approved R&D And CDMO Outlook 2023
BRIEF published on 06/04/2025 at 17:50, 8 months 1 day ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
Published on 02/06/2026 at 00:57, 4 hours 11 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 5 hours 8 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 5 hours 53 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 6 hours 8 minutes ago Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 8 hours 8 minutes ago Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions
Published on 02/05/2026 at 19:27, 9 hours 40 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 10 hours 22 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 10 hours 58 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 11 hours 12 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:05, 12 hours 2 minutes ago European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 18:06, 11 hours 1 minute ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 11 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
